Management ChangeMay 22, 2026, 05:27 PM
Maze Therapeutics SVP Finance Amy Bachrodt Resigns
AI Summary
Maze Therapeutics announced that Amy Bachrodt resigned from her position as Senior Vice President, Finance, effective June 1, 2026. The company stated that her resignation was not a result of any disagreement regarding operations, policies, practices, or financial reporting. Following her departure, Misbah Tahir, the current Chief Financial Officer, will assume the role of principal accounting officer.
Key Highlights
- Amy Bachrodt resigned as Senior Vice President, Finance of Maze Therapeutics.
- Her resignation is effective June 1, 2026.
- The resignation was not due to any disagreement with the company.
- Misbah Tahir, CFO, will be designated principal accounting officer after Ms. Bachrodt's departure.
Price Impact
More from MAZE